Genuphil

Genuphil
Product Description

Eva pharma manufactures wide range of pharmaceutical products which includes genuphil. Therapeutic category: joints pain. It is the ultimate joint care formula that contains the essential components responsible for maintaining the normal structure of the articular cartilage and synovial fluid of the joints & reduces the pain and inflammation associated with these conditions. It is indicated in treatment of all types of osteoarthritis & other painful and degenerative joint conditions, improve movement of joints in elderly and decrease pain of musculoskeletal disorders, etc. Packaging: blister of 10 film coated tablets in boxes of two or three blisters.

Eva Pharma

  • EG
  • 2015
    On CPHI since
Specifications
  • Details
    leflunomide 20mg, leflunomide 100mg, etc.

Eva Pharma

  • EG
  • 2015
    On CPHI since

More Products from Eva Pharma (4)

  • Acnidu

    Product Acnidu

    Eva pharma manufactures wide range of pharmaceutical products which includes acnidu. Therapeutic category: skin problems. It is indicated for the topical treatment of acne vulgaris. Packaging: carton box containing 3 containers (2 plastic containers and 1 glass vial).
  • Aphthtab

    Product Aphthtab

    Eva pharma manufactures wide range of pharmaceutical products which includes aphthtab. Therapeutic category: men's health. It is indicated for the treatment of aphthous ulcers in adults and adolescents 12 years of age and older, use in children below age 12 or in patients with abnormal immune system.
  • Aphthtab

    Product Aphthtab

    Eva pharma manufactures wide range of pharmaceutical products which includes aphthtab. Therapeutic category: men's health. It is indicated for the treatment of aphthous ulcers in adults and adolescents 12 years of age and older, use in children below age 12 or in patients with abnormal immune system.
  • Aphthtab

    Product Aphthtab

    Eva pharma manufactures wide range of pharmaceutical products which includes aphthtab. Therapeutic category: men's health. It is indicated for the treatment of aphthous ulcers in adults and adolescents 12 years of age and older, use in children below age 12 or in patients with abnormal immune system.